Myomo, Inc.

MYO Medical devices

Develops myoelectric upper limb orthoses for people with neuromuscular disorders.

Jun 2026Revenue $43.3M/yrExpenses $55.0M/yr
No trendCash runway ≈ 1.6 years from Jun 2026
Figures by year

When will Myomo be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $43.3M and expenses $55.0M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$40.9M$55.3M−$14.4M
Dec 2024$32.6M$38.8M−$6.21M
Dec 2023$19.2M$27.5M−$8.23M
Dec 2022$15.6M$26.2M−$10.7M
Dec 2021$13.9M$24.1M−$10.3M
Dec 2020$7.58M$18.1M−$10.5M
Dec 2019$3.84M$14.6M−$10.8M
Dec 2018$2.44M$13.0M−$10.5M
Dec 2017$1.56M$8.11M−$6.55M
Dec 2016$1.10M$4.38M−$3.28M